Earnings Feed
Start Free
Natera, Inc.·4

Mar 3, 9:05 PM ET

Moshkevich Solomon 4

4 · Natera, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Natera, Inc.NTRA
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-02-27+10,051→ 147,898 total
  • Exercise/Conversion

    Common Stock

    2026-03-02$9.59/sh+5,125$49,149→ 153,023 total
  • Sale

    Common Stock

    [F3][F4]
    2026-03-02$198.83/sh−931$185,114→ 152,092 total
  • Sale

    Common Stock

    [F3][F5]
    2026-03-02$200.11/sh−1,594$318,971→ 150,498 total
  • Sale

    Common Stock

    [F3][F6]
    2026-03-02$200.97/sh−475$95,460→ 150,023 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F7]
    2026-03-02−5,125→ 0 total
    Exercise: $9.59Exp: 2026-04-07→ Common Stock (5,125 underlying)
Footnotes (7)
  • [F1]Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.42 to $199.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.6750 to $200.5100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.72 to $201.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The option shares are fully exercisable.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    form4-03032026_090301.xmlPrimary